Thumbnail Image
Item

An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis

Lekamwasam, S.
; 
Adachi, Jonathan D.
; 
Agnusdei, D.
; 
Bilezikian, J P.
; 
Boonen, S.
; 
Borgström, F.
; 
Cooper, Cyrus
; 
Perez, A. Diez
; 
Eastell, Richard
; 
Hofbauer, L. C.
... show 10 more
Citations
Google Scholar:
Lookup
Altmetric:
Author
Lekamwasam, S.
Adachi, Jonathan D.
Agnusdei, D.
Bilezikian, J P.
Boonen, S.
Borgström, F.
Cooper, Cyrus
Perez, A. Diez
Eastell, Richard
Hofbauer, L. C.
Kanis, John A.
Langdahl, B. L.
Lesnyak, Olga
Lorenc, R. S.
McCloskey, Eugene
Messina, O. D.
Napoli, N.
Obermayer-Pietsch, B.
Ralston, Stuart H.
Sambrook, Philip N.
Silverman, S.
Sosa, M.
Stepan, Jan J.
Suppan, G.
Wahl, D. A.
Compston, Juliet E.
Abstract
The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
Keywords
Glucocorticoids, bone mineral density, fracture, FRAX, bone protective therapy
Date
2012
Type
Journal article
Journal
Archives of Osteoporosis
Book
Volume
7
Issue
2017-02-01
Page Range
25-30
Article Number
ACU Department
Mary MacKillop Institute for Health Research
Faculty of Health Sciences
Collections
Mary MacKillop Institute for Health Research
Show all metadata
URI
https://hdl.handle.net/20.500.14802/23411
Relation URI
DOI
10.1007/s11657-012-0070-7
Source URL
Event URL
Open Access Status
License
File Access
Controlled
Notes